Main > HEPATOLOGY > Hepatitis B Virus > Infection. Treatment > Thymosin Alpha-1 (Peptide) > Co.: USA. S (Development/Patents) > Status> > MonoTherapy>Phase III (Japan)> > Completed>

Co. completed a phase 3 clinical trial in Japan using drug as a monotherapy to treat patients chronically infected with HBV. The study showed that 20% of patients treated with drug achieved a sustained response and no significant side effects were noted


Completed>'s products
This section has no products